ROVILaboratorios Farmaceuticos Rovi, S.A.
59.40EUR-0.42%Mkt Cap: 3.02B EURP/E: 24.98Last update: 2026-05-14

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, B…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)24.98
P/E (Forward)15.52
PEG1.26
P/B4.54
P/S4.06
EV/EBITDA17.73
EV/Revenue4.66
EPS (TTM)2.36
EPS (Forward)3.80
Cash Flow & Leverage
FCF Yield2.73%
FCF Margin11.07%
Operating CF138.28M EUR
CapEx (TTM)62.22M EUR
Net Debt/EBITDA0.12
Net Debt23.22M EUR
Technical
SMA 5078.14 (-24.0%)
SMA 20067.25 (-11.7%)
Beta0.29
S&P 52W Chg24.23%
Avg Vol (30d)168.03K
Avg Vol (10d)301.10K
Technical Indicators
RSI (14)13.4
MACD-5.6993
MACD Signal-3.4882
MACD Hist.-2.2110
BB Upper95.55 EUR
BB Middle75.27 EUR
BB Lower54.98 EUR
BB Width53.89%
ATR (14)3.396 EUR
Vol Ratio (20d)0.71x
52W Range
50.9024% of range86.70
52W High86.70 EUR
52W Low50.90 EUR
Profitability
Gross Margin62.63%
EBITDA Margin26.30%
Profit Margin17.92%
Oper. Margin25.15%
ROE23.93%
ROA16.45%
Revenue Growth9.70%
Earnings Growth82.50%
Balance Sheet
Debt/Equity0.20
Current Ratio3.13
Quick Ratio1.51
Book Value/Sh12.99 EUR
Cash/Share1.928 EUR
Dividends
Fwd Div Rate0.9400 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.39%
5Y Avg Yield1.59%
Payout Ratio39.58%
Ex-Div DateJul 14, 2025
Pay Date
Ownership
Shares Out.51.15M
Float16.30M
Insiders68.03%
Institutions19.49%
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)82.30 EUR
Target Range67.00 EUR100.00 EUR
# Analysts9
Company
Market Cap3.02B EUR
Enterprise Value3.47B EUR
Revenue (TTM)743.48M EUR
Gross Profit478.35M EUR
Net Income (TTM)136.88M EUR
Revenue/Share14.54 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1.9K
Last Price59.40 EUR
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0157261019